X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-02 | GNCA | Duvall Diantha | CFO | S - Sale | $0.06 | -1,355 | 75,388 | -2% | -$81 | ||||||
2022-06-02 | GNCA | Flechtner Jessica Baker | Chief Scientific Officer | S - Sale | $0.06 | -1,578 | 89,027 | -2% | -$95 | ||||||
2022-06-02 | GNCA | Clark William D | Pres, CEO | S - Sale | $0.06 | -4,023 | 304,377 | -1% | -$241 | ||||||
2022-06-01 | GNCA | Sumer Jacquelyn L | CHIEF LEGAL, COMPLIANCE OFF | S - Sale | $0.06 | -2,500 | 43,000 | -5% | -$150 | ||||||
2022-05-31 | GNCA | Clark William D | Pres, CEO | S - Sale | $0.06 | -117,244 | 308,400 | -28% | -$7,234 | ||||||
2022-05-27 | GNCA | Siber George | Dir | S - Sale | $0.07 | -20,425 | 252 | -99% | -$1,334 | ||||||
M | 2022-05-24 | GNCA | Walker Paul Edward | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Sonsini Peter W. | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Sandell Scott D | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | New Enterprise Associates 16, L.P. | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Makhzoumi Mohamad | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Florence Anthony A. Jr. | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Chang Carmen | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Behbahani Ali | Dir, 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
M | 2022-05-24 | GNCA | Baskett Forest | 10% | S - Sale | $0.07 | -10,376,936 | 0 | -100% | -$750,662 | |||||
2022-05-25 | GNCA | Flechtner Jessica Baker | Chief Scientific Officer | S - Sale | $0.09 | -16,525 | 90,605 | -15% | -$1,456 | ||||||
2022-05-26 | GNCA | Duvall Diantha | CFO | S - Sale | $0.08 | -24,407 | 76,743 | -24% | -$1,867 | ||||||
2022-04-04 | GNCA | Flechtner Jessica Baker | Chief Scientific Officer | S - Sale | $1.25 | -1,212 | 96,193 | -1% | -$1,515 | ||||||
2022-04-04 | GNCA | Duvall Diantha | CFO | S - Sale | $1.25 | -963 | 91,775 | -1% | -$1,204 | ||||||
2022-04-04 | GNCA | Davis Thomas Andrew | CHIEF MEDICAL OFFICER | S - Sale | $1.25 | -1,091 | 68,330 | -2% | -$1,364 | ||||||
2022-04-04 | GNCA | Clark William D | Pres, CEO | S - Sale | $1.25 | -3,924 | 369,487 | -1% | -$4,905 | ||||||
2022-04-04 | GNCA | Aakalu Girish N | CHIEF BUSINESS OFFICER | S - Sale | $1.25 | -963 | 74,459 | -1% | -$1,204 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |